| # | Drug | Count |
|---|---|---|
| 0 | ENZALUTAMIDE | 29 |
| 1 | FUROSEMIDE | 17 |
| 2 | DABIGATRAN ETEXILATE | 16 |
| 3 | ESCITALOPRAM | 15 |
| 4 | ESCITALOPRAM OXALATE | 15 |
| 5 | ESCITSLOPRAM | 15 |
| 6 | METOPROLOL | 14 |
| 7 | METOPROLOL TARTRATE | 14 |
| 8 | APIXABAN | 12 |
| 9 | METOPROLOL TARTRATE INJECTION | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOFERSEN | 1 | 0.0018 |
| 1 | ADENOSINE | 2 | 0.0012 |
| 2 | OMAVELOXOLONE | 1 | 0.0006 |
| 3 | ENZALUTAMIDE | 29 | 0.0005 |
| 4 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 5 | RILUZOLE | 1 | 0.0004 |
| 6 | CALCIFEDIOL | 1 | 0.0004 |
| 7 | DILTIAZEM HYDROCHLORIDE | 7 | 0.0002 |
| 8 | VASOPRESSIN | 1 | 0.0002 |
| 9 | DABIGATRAN ETEXILATE | 16 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Benzothiazole [EPC] | 1 | 0.0004 |
| 2 | Androgen Receptor Inhibitor [EPC] | 29 | 0.0004 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 4 | Adenosine Receptor Agonist [EPC] | 2 | 0.0003 |
| 5 | Cardiac Myosin Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 11 | 0.0001 |
| 9 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |